Option Care Health, Inc. (OPCH)

Market Cap	4.75B
Revenue (ttm)	5.53B
Net Income (ttm)	209.21M
Shares Out	158.73M
EPS (ttm)	1.27
PE Ratio	23.54
Forward PE	20.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,720,015
Open	30.20
Previous Close	30.26
Day's Range	29.49 - 30.34
52-Week Range	22.29 - 35.53
Beta	0.80
Analysts	Buy
Price Target	36.00 (+21.09%)
Earnings Date	Oct 30, 2025

About OPCH

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic art...

• Industry: Medical Care Facilities
• Sector: Healthcare
• CEO: John Rademacher
• Employees: 8,088
• Stock Exchange: NASDAQ
• Ticker Symbol: OPCH
• Website: https://www.optioncarehealth.com

Financial Performance

In 2024, Option Care Health's revenue was $5.00 billion, an increase of 16.17% compared to the previous year's $4.30 billion. Earnings were $211.82 million, a decrease of -20.69%.

Analyst Summary

According to 7 analysts, the average rating for OPCH stock is "Buy." The 12-month stock price target is $36.0, which is an increase of 21.09% from the latest price.

Price Target

$36.0

(21.09% upside)

Analyst Consensus: Buy